Jaguar Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Jaguar Health generated cash of -$33,241,999, which is less than the previous year. Cash used in financing activities reached the amount of $34,227,000 last year. Net change in cash is therefore $1,000,000.
Cash Flow
| 2014 | -5.46M | -55.14K | 6.17M |
|---|---|---|---|
| 2015 | -14.31M | -3.00M | 24.17M |
| 2016 | -14.41M | 2.38M | 5.28M |
| 2017 | -9.82M | -1.28M | 10.67M |
| 2018 | -22.73M | -6.52K | 24.54M |
| 2019 | -20.45M | 0 | 21.77M |
| 2020 | -15.27M | -7K | 19.49M |
| 2021 | -34.97M | -6K | 43.93M |
| 2022 | -33.10M | -1.67M | 23.18M |
| 2023 | -33.24M | 0 | 34.22M |
JAGX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.46M | 17.05M | 8.09M | 3.88M | 2.56M | 759.86K | 950.97K | 7.69M | 845.19K | 185.36K |
Operating activities | ||||||||||
Net income | -41.3M | -49.07M | -52.6M | -33.80M | -38.53M | -32.14M | -21.96M | -14.73M | -16.29M | -8.60M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 13.58M | 2.29M | 1.81M | 2.28M | 1.92M | 1.31M | 584.33K | 47.49K | 5.15K | 0 |
Stock-based compensation expense | 2.11M | 3.31M | 3.97M | 2.82M | 2.98M | 0 | 814.61K | 717.92K | 992.16K | 164.15K |
| Deferred income tax benefit | 2.11M | 3.31M | 3.97M | 2.82M | 2.98M | 0 | 814.61K | 717.92K | 992.16K | 164.15K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -88K | -170K | 2.82M | -2.84M | -696.02K | -528.02K | -166.05K | 50.90K | -55.86K | 1.08M |
Inventories | -2.16M | -2.12M | -2.11M | -653K | 1.21M | -1.26M | 128K | -182.88K | -31.84K | -198.02K |
Accounts payable | -855K | 902K | 158K | -743K | -62.72K | -1.94M | 4.18M | -28.33K | -240.08K | 689.32K |
Cash generated by operating activities | -33.24M | -33.10M | -34.97M | -15.27M | -20.45M | -22.73M | -9.82M | -14.41M | -14.31M | -5.46M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3M | 0 |
Investments In Property Plant And Equipment | 0 | -1.67M | -6K | -7K | 0 | -6.52K | 0 | -104.20K | -23.3K | -55.14K |
Acquisitions Net | 1.23M | 0 | 247K | 0 | 0 | 0 | -1.55M | 0 | 20.6K | 0 |
Cash generated by investing activities | 0 | -1.67M | -6K | -7K | 0 | -6.52K | -1.28M | 2.38M | -3.00M | -55.14K |
Financing activities | ||||||||||
Common Stock Issued | 32.71M | 20.46M | 33.57M | 1.94M | 6.62M | 16.68M | 10.30M | 8.82M | 18.81M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 33K | 0 | -30 | 0 | 0 | 0 | 0 |
Repayments of term debt | -100K | 3.87M | -1.92M | -1.08M | -100K | -2.25M | 377.90K | -2.48M | 5.76M | 0 |
Cash used in financing activities | 34.22M | 23.18M | 43.93M | 19.49M | 21.77M | 24.54M | 10.67M | 5.28M | 24.17M | 6.17M |
Net Change In Cash | 1M | -11.58M | 8.96M | 4.20M | 1.31M | 1.80M | -430.28K | -6.74M | 6.85M | 659.82K |
Cash at end of period | 6.46M | 5.46M | 17.05M | 8.09M | 3.88M | 2.56M | 520.69K | 950.97K | 7.69M | 845.19K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |